Abstract
Pancreatic lipase activity and bile salt concentration are very low in infants. Therefore, infant formula (IF) preparation with structured lipids (SLs) containing essential fatty acids and medium-chain fatty acids (MCFAs) with easy absorption features has attracted great attention. In this work, the lipid composition and physiochemical properties of novel SLs enriched with medium- and long-chain triacylglycerols (MLCTs) and their incorporation into a powdered IF compared to commercial IFs were evaluated. The obtained results showed that the SL contains arachidonic (ARA), caprylic, and capric as major fatty acids (FAs). Further, the evaluation of commercial IFs oil showed that oleic, linoleic, palmitic, and lauric were the most abundant FAs. A novel SL possessed highest levels of MCFAs (36.33 ± 1.05%) at sn-1,3 positions and LCUFAs (65.91 ± 1.32%) at the sn-2 position especially ARA (42.82 ± 0.89%). A total of 45, 38, and 25 triacylglycerols molecular species were revealed in a novel SL and commercial IFs available in China and the USA, respectively. Thermoprofile revealed that all IFs oil samples melted below the body temperature. The formula produced with microencapsulated SL and the dry-mixing process showed better optical properties and oxidative stability having lower moisture content. The study has potential applications in the development of IF with improved properties.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Human breast milk is considered as the best food for infants in terms of nutritional value, immunity enhancement, and safety. In addition, it provides about 40—60% of total energy required for the infants through lipids [1]. However, the provision of infants with breast milk is not always possible due to number of reasons, such as time constraints, challenges associated with urbanization, and poor health conditions of the mother or baby, which may influence the early termination of feeding infants breast milk. Therefore, infant formulas (IFs) were developed to imitate the composition of a healthy mother’s breast milk [2]. One of the important properties of IFs is the content and type of structured lipids (SLs) that used as a lipid ingredient. These have been reported to supply quick energy and essential fatty acids (EFAs), such as arachidonic acid (ARA), for the construction of an infant’s cell membranes and normal function of cells [3]. Most commercial IFs are based on the biological conversion of alpha-linolenic acid and linoleic acid to long-chain unsaturated fatty acids (LCUFAs) containing docosahexaenoic acid and ARA, respectively [4]. Therefore, substitute approaches are used for introducing these useful LCUFAs in IF products [5, 6]. In recent years, the preparation of SLs containing functional LCUFAs in the sn-2 position, such as ARA and medium-chain fatty acids (MCFAs), at sn-1,3 positions has attracted a lot of attention. LCUFAs’ existence at the sn-2 position enhances the absorption of monoacylglycerols (2-MAG) [7,8,9]. ARA is one of the EFAs that exists in human milk but usually not found in IF products. ARA is necessary for the normal growth and function of the brain and retina in infants. Furthermore, ARA constitutes one of the major fatty acids (FAs) in brain, assisting in the protection and development of nervous system functions [3, 10].
Although most conventional IFs are frequently enhanced with lauric acid as a source of MCFAs, the studies on the relationship between the metabolic fate of different kinds of FAs and the chain length have brought misconception about its classification. To this end, some researchers have considered lauric acid as a long-chain fatty acid (LCFA) instead of MCFA [11, 12]. Previous studies recommended the use of capric and caprylic acids as a source of MCFAs in IF products due to their functional and nutritional effects [13, 14]. Medium- and long-chain triacylglycerols (MLCTs) are defined as a type of SLs where the individual triacylglycerol (TAG) molecule consists of both LCFAs and MCFAs attached on the same glycerol molecule [15]. MLCTs are present in food products, such as Resetta™ (Nisshin Oillio Group Ltd., Japan), that have several physiological benefits, like cholesterol maintenance capability and anti-obesity effects [16]. Moreover, MLCTs have the superior ability to provide the body with quick energy and EFAs; hence, they are very beneficial for enhancing human health, especially for infants [17].
Enzymatic interesterification is one of the methods utilized in the production of MLCTs and modification of fats and oils properties for possible IF applications and some other purposes too [18]. Despite the health benefits that MLCTs possess, the incorporation of MLCTs into IFs as a lipid ingredient is a challenge, as these lipid components are prone to oxidation and evolution of unpleasant flavor volatiles affect sensory characteristics [6, 19]. Recently, the late addition of lipid ingredients that have LCUFAs during IF production has been reported to reduce the oxidation of lipids [3]. During the production of powdered IF, SLs containing ARA as LCUFAs can be added after the spray-drying procedure as a microencapsulated powder using a traditional blender [20]. For the microencapsulation of SLs used in IFs, food-grade components appropriate for infants and natural constituents are preferred. Whey proteins are among the milk constituents that improve the nutritional value of IFs. They are widely used as an encapsulating agent in the food industry for emulsifying, building viscosity, and gel formation. Additionally, whey proteins have been used in combination with carbohydrates, such as inulin (IN), to stabilize spray-dried emulsions [21, 22]. IN is a natural source of carbohydrates that is obtained from chicory roots, yacon tubers, wheat, asparagus, Jerusalem artichoke, and onions [23]. IN from chicory roots is available in the market and is used as a refined food ingredient, because of its nutritive value and other superior properties [24]. IN can also be used as a fat replacer, texture modifier, encapsulation agent, and emulsion stabilizer because of its water-holding capability [25]. IN has many beneficial effects on human health, such as the promotion of gastrointestinal tract function, improvement of minerals absorption, and reduction of appetite modulation [26]. Furthermore, IN is considered as one of the food-grade oligosaccharides for the provision of prebiotics [27]. Previous in vitro and in vivo studies demonstrated that the microencapsulation of oil can protect it from stomach acidic conditions for the delivery and release of the oil into the small intestine. Moreover, it also maintains the bioavailability of the oil [28, 29].
In our previous work [30, 31], a novel SL enriched with ARA and MCFAs was synthesized and encapsulated with different wall materials. The objective of this study was to evaluate the application of a potential novel functional SL as a lipid ingredient in the production of IFs. To identify the relation between SLs enriched with MLCTs and the oil extracted from two commercial IFs samples, the compositions of FAs, sn-2 FAs position, and TAG species were determined. In addition, the thermal behaviors of the three oil samples were evaluated using differential scanning calorimetry (DSC). Moreover, UPLC-Q-TOF-MS was utilized as a rapid method to comprehensively quantify TAG species. Powdered IFs with a novel functional SL were prepared by two manufacturing approaches. Later, the quality of powdered IFs was evaluated in terms of oxidative stability (peroxide value), moisture content, water activity, and color. The study has potential applications in the development of IF with improved properties.
Materials and methods
Materials
Purified SLs enriched with MLCTs were produced in our previous studies through the interesterification reaction between ARA-rich single-cell oil with medium-chain triacylglycerols in a solvent-free system using Lipozyme 435 lipase [30, 31]. Two samples of commercial IFs from different companies were used; the first sample CIFL (1) was purchased from China and the second sample CIFL (2) was obtained from the USA. A standard mixture of fatty acids methyl ester (FAMEs), porcine pancreatic lipase (1000–4000 U g-1), and Cumene hydroperoxide standard (80% purity) were obtained from Sigma-Aldrich Chemical Co., Ltd. (Shanghai, China). Silica gel thin-layer chromatography plates (10 × 20 cm; 60 Å mean the diameter of the pore, 2–25 µm mean the size of the particle, 500 µm thickness, with dichlorofluorescein) were bought from Shanghai Shangbang Decoration Materials Co., Ltd. (Shanghai, China). Methanol, chloroform, acetonitrile, isopropanol, and n-hexane used for ultra-performance liquid chromatography (UPLC) analysis were chromatographic pure from Fisher (Fair Lawn, NJ, USA). Whey protein isolate (WPI, BiPro, ~ 92%) was purchased from Davisco Foods International Inc. (Le Sueur, Minnesota, USA). Inulin (IN, degree of polymerization ≥ 23) was obtained from Orafti®HP, BENEO-Orafti. Maltodextrin and lactose were purchased from Xiwang International Trade Co. Ltd., China. Non-fat dry milk was bought from Globe-milk B.V., Holland. Micronutrient premix mainly consisting of vitamins and minerals (Table 1) was obtained from Usp Co., Ltd. (Headquarters Rockville, Maryland, USA). All other organic solvents and chemicals used for extraction and analysis were of analytical and chromatographic grade.
Extraction process of total oil
Total oil was extracted from commercial IF samples according to Floch [32]. Commercial IF samples (16 g) were dissolved in 200 mL mixture of chloroform/methanol (2:1, v/v). The mixture was then shaken for 15 min and centrifuged for 10 min at 4500 rpm. The organic phase that contained the total lipids was collected in separation funnel and then equilibrated by mixing with a one-fourth volume of a saline sodium chloride solution (0.86%, w/w). The lower chloroform layer was separated, filtered, and evaporated at 40 °C under reduced pressure. The resultant total oils were flushed with nitrogen and stored at − 20 °C until further analysis.
The physicochemical properties of a novel SL and infant formula oil
FAs composition analysis
The FAs composition of the purified SLs enriched with MLCTs and the oil extracted from commercial IF samples was analyzed as FAMEs following the procedure reported by Pande et al. [33]. FAMEs were identified and quantified using gas chromatography (Agilent 7820A) equipped with a flame ionization detector and a Trace TR-FAME capillary column (60 m × 0.25 mm × 0.25 µm, Thermo Fisher, USA). The column was initially maintained at 60 °C for 3 min, followed by temperature programming to 175 °C at the rate of 5 °C/min, then held at 175 °C for 15 min, and then raised by 2 °C/min to a final temperature of 220 °C for 10 min. The temperature of the injector and the detector was set at 250 °C. Nitrogen was used as a carrier gas with a flow rate of 1.2 mL/min, a split ratio of 1:100; detector gas 30 mL/min hydrogen, 400 mL/min air and 25 mL/min nitrogen. The running time of each sample was set at 73.5 min. FAMEs were identified by comparing the retention times of sample peaks with the corresponding known standards. The relative contents were expressed as weight percentage (%, w/w) and then calculated. Analyses were performed in triplicate.
Sn-2 FAs composition analysis
Pancreatic lipase catalysis was used to determine FAs composition at the sn-2 position of the purified SLs enriched with MLCTs and the oil extracted from commercial IF samples by means of the method described by Sun et al. [34]. Briefly, 1 mL of 1 M Tris–HCl buffer (pH 8.0), 0.25 mL of 0.05% bile salts, 0.1 mL of 2.2% CaCl2, and 20 mg of pancreatic lipase were mixed with each sample (0.1 g). The mixture was placed in a water bath at 40 °C for 3 min with shaking (three times), and 1 mL of 6 M HCl solution and 2 mL of diethyl ether were added and centrifuged for 5 min at 4500 rpm. After that, the upper layer was collected, and diethyl ether was dried by anhydrous sodium sulfate and evaporated under nitrogen to 0.5 mL. The hydrolysis products were then extracted and separated by silica gel thin-layer chromatography plates with a developing solvent system of hexane/diethyl ether/acetic acid (50:50:1, v/v/v). The 2-MAG band was located by viewing under ultraviolet light. Finally, the band corresponding to 2-MAG was scraped off for methylation, and FAs composition was analyzed using gas chromatography as previously described. Analyses for each sample were repeated three times.
Separation and determination of TAG species
TAG species of the purified SLs enriched with MLCTs and the oil extracted from commercial IF samples were identified using an UPLC system (Waters, Milford, Massachusetts, USA) equipped with a BEH C18 analytical column (i.d. 2.1 × 50 mm, 1.9 µm) following the procedure reported by Ali et al. [35]. The temperatures of the column and the sample chamber were set at 45 and 20 °C, respectively. The injection volume of each analysis was 1.0 µL with a concentration of 1 mg/mL. The separation of TAG species from the samples was completed using acetonitrile/isopropanol (1:9, v/v) as a mobile phase (A) and acetonitrile/water (4:6, v/v) as a mobile phase (B). Ammonium acetate (10 mM) was added to the two mobile phases as an electrolyte and the flow rate was set at 300 µL/min. Complete separation of TAG species from the samples was performed with a binary gradient started with 70% of phase (A) and held for 1 min, then raised to 87% for 30 min and held also for 1 min, and then returned to the initial rate of 70% for 1 min and equilibrated for 4 min. Before the beginning of the next analysis, the column was cleared with 5% of the mobile phase (A) for 5 min.
A Q-TOF-MS instrument (Waters, Milford, Massachusetts, USA) with electrospray ionization positive ion mode was applied for TAGs identification and quantification. The optimal conditions of positive ion mode were set as follows: source temperature (400 °C), capillary voltage (3.5 kV), cone voltage (30 V), collision gas (argon), desolvation gas (nitrogen), and flow rate (700 L/h). Full scan spectra were detected for 0.5 s scan duration in the range of m/z 200–1500. The collision energy was set as 5 eV and 20–50 V ramp for low-energy and high-energy scans, respectively. Mass-Lynx software (4.1, Waters) was used to analyze the raw obtained data.
Melting and crystallization profiles
The melting and crystallization properties of the purified SLs enriched with MLCTs and the oil extracted from commercial IF samples were carried on a DSC (Q2000 V4.7A Build 121, TA Instruments, New Castle, DE, USA) equipped with a refrigerated cooling system according to the method reported by Korma et al. [30]. Indium, eicosane, and dodecane standards were used to perform the calibration before the analysis. 5–8 mg of each sample was weighed in 30 μL aluminum pans and sealed hermetically. An empty pan was used as a reference during the measurements. The sample was heated from 25 to 80 °C at a rate of 50 °C/min and kept at 80 °C for 10 min (to destroy any previous crystalline structure), then decreased to − 65 °C at a rate of 10 °C/min and held at − 65 °C for 10 min (for crystallization profiles), and finally heated to 80 °C at a rate of 5 °C/min (for melting profiles). Nitrogen gas was used to purge the system at 20 mL/min during the analysis. Thermal solutions software (TA Instruments) was used to analyze the melting and crystallization profiles.
IFs preparation
Usually, IFs are produced using fat, protein, carbohydrate, and micronutrients premix (minerals and vitamins) to mimic the composition of a healthy mother’s breast milk [36, 37]. Purified SLs enriched with MLCT-containing IFs were formulated using two common manufacturing methods: (A) a wet-blending/ spray-drying process and (B) a dry-mixing process. In the wet-mixing/spray-drying process, constituents are mixed together, homogenized, pasteurized, and spray-dried to produce a powdered product as follows: Non-fat dry milk (20 g), WPI (10 g), maltodextrin (30 g), lactose (31 g), and water (800 mL) were mixed at 50–60 °C by stirring mildly and allowed to hydration for 30 min prior addition of SLs enriched with MLCTs (30 g) and micronutrients premix (3.9 g). The mixture was then mixed using a high-speed homogenizer (Ultra-Turrax IKA T18 basic, Wilmington, NC, USA) at 22,000 rpm for 4 min at room temperature, then passed through an ATS AH2100 high-pressure homogenizer (AH- 2010, ATS Engineering Inc., Canada) operated at 40 MPa with 4 processing cycles. After that, the mixture was pasteurized at 65 °C for 30 min, and then spray-dried by a GEA Niro spray dryer (model Mobile MinorTM, Soborg, Denmark), using inlet and outlet temperatures of (180 ± 5 °C) and (80 ± 5 °C), respectively. The airflow rate set at 300 NL min−1 and the mixture was fed into the drying chamber at the feed flow rate of 14–15 mL min−1 using a peristaltic pump. The dried powder was collected and stored in sealed plastic bags at − 20 °C for further analysis.
In the dry-mixing process, before the mixing step between the ingredients as a dehydrated powdered, SLs enriched with MLCTs were encapsulated by the composition of WPI with IN (1:1), since it was the best combination as a wall material as described in our previous study [31]. The microencapsulated SLs enriched with MLCTs (85 g) were then dry-mixed with the constituents recorded above except for water. The influences of these two methods on product quality were evaluated and compared to two products of commercial IFs.
Characterization of powdered IFs
Determination of peroxide value
The peroxide value of powdered IF samples was determined using a method recommended by Sharif et al. [38] with minor modifications. 0.5 g of each powdered sample was reconstituted in 5 mL purified water and stirred for rehydration. An amount of 1 mL of rehydrated emulsion sample was taken into a 10 mL glass tube. Then, 5 mL of chloroform/methanol (2:1 v/v) was added. The obtained mixture was vortexed three times (10 s each) followed by centrifugation at 2000 rpm for 4 min. The organic solvent phase (0.2 mL) was added to 2.8 mL of chloroform/methanol (2:1 v/v), followed by 15 µL of ammonium thiocyanate solution (3.94 M), and 15 µL of ferrous iron solution. The final mixture was vortexed again, and the absorbance of the samples was measured at 510 nm after kept the samples in dark at room temperature for 20 min. Lipid hydroperoxide concentrations were determined from a Cumene hydroperoxide standard curve [Standard curve eq. Y = 0.2808 X + 0.0301 and coefficient correlation (R2) = 0.9983]. The analysis was repeated three times.
Determination of moisture content and water activity
The moisture content and water activity were determined by means of the method described by Korma et al. [31]. The moisture content of powdered IF samples was measured using digital moisture balances (Moisture analyzing Lab Equipment, Ohaus). While, the water activity was determined by the Novasina water activity meter (Labswift-aw, Novasina AG, Lachen, Switzerland) at 25 °C. Time of analysis was different from one sample to another and results were recorded after reaching the equilibrium. Samples were placed in the sample dish in a thin layer during the analysis, triplicate for each sample.
Determination of Hunter color values
The color measurements of powdered IF samples were detected using a Colorimeter (Minolta Company Ltd., Osaka, Japan). The findings of L*, a*, and b* were expressed as (lightness), (red to green), and (yellow to blue), respectively. According to Ahmed et al. [39], the values of Chroma (C*) and hue angle (h*) were calculated from a* and b* values. The mathematic C* and h* are defined as C* = [a*2 + b*2]1/2 and h* = tan−1 [b*/a*]. Color change (ΔE) was calculated as ΔE = [(Δ L*)2 + (Δ a*)2 + (Δ b*)2]1/2. Prior to the analysis, the instrument was standardized with a white reference tile, triplicate for each sample.
Data analysis
The experimental data were evaluated by one-way analysis of variance (ANOVA) using statistical analysis software (version 6.4, CoStat, Monterey, CA, USA). The findings were stated as mean ± standard deviation. The P values of less than 0.05 were considered statistically significant for the results.
Results and discussion
Composition of FAs
The FA profile of the purified SLs and extracted fat from CIFL (1) and CIFL (2) are presented in Table 2. In the synthesized SLs, the most abundant FAs were ARA (34.46%), caprylic (17.33%), capric (12.69%), and lignoceric (8.16%) acids. The percentages of LCUFAs, LCFAs, and MCFAs were 49.42%, 20.56%, and 30.01%, respectively. The synthesized SLs had high contents of ARA and MCFAs on the same glycerol molecules, and it would provide advantages in the medical field with various therapeutic approaches and also help to maintain the nutritional requirements for the health [18, 40]. In CIFL (1), the most abundant FA was oleic acid (35.16%), followed by linoleic (23.05%), palmitic (14.53%), and lauric (6.09%) acids. The percentages of LCUFAs, LCFAs, MCFAs, and SCFAs were 61.66, 25.31, 8.37, and 4.66%, respectively. The major FA in CIFL (2) was oleic acid (42.68%), followed by linoleic (20.28%), lauric (12.79%), and palmitic (8.30%) acids. The percentages of LCUFAs, LCFAs, and MCFAs were making up 66.26, 18.16, and 15.57%, respectively. The high ratios of beneficial LCUFAs are largely necessary for human nutrition. In previous study, it was discovered that LCUFA-rich oils have the ability to avoid several human diseases, such as cardiovascular diseases [41]. The differences in FA percentages of the commercial IFs, CIFL (1) and CIFL (2), were made be due to the variances in sources of plant oils blend used in the composition of the fat product.
Positional distribution of FAs
The FAs distribution in oils acts a crucial role in their availability and functions. Thus, its study has attracted great attention in human nutrition. The absorption, distribution, and metabolism of TAGs are linked to the FAs location. FAs emitted from sn-1,3 positions have been known to have different metabolic destinies than those at the sn-2 position [42]. The positional distribution of FAs on the glycerol backbone of SLs, CIFL (1), and CIFL (2) samples is displayed in Table 2. The findings of this study showed that ARA (42.82%) was the most abundant FA in SLs that occupied the sn-2 position followed by capric (10.47%) and linoleic (7.84%) acids. In CIFL (1), the predominant FA-occupied sn-2 position was linoleic acid (24.58%), followed by oleic (20.43%), lauric (16.17%), and palmitic (15.78%) acids. While in CIFL (2), lauric, oleic, linoleic, stearic, and palmitic acids were the major FAs occupied in the sn-2 position accounted for 35.28, 17.6, 17.23, 10.38, and 8.68%, respectively. In previous studies, suggested that ARA-enriched oils at the sn-2 position show the best intestinal absorption conditions with various benefits in clinical nutrition [42, 43]. Moreover, higher levels of ARA were detected in the brain of newborn rats fed with ARA-enriched oils at the sn-2 position rather than randomly distributed [44]. Most commercial IFs are based on the biological conversion of linoleic acid to ARA, but the ratios for these conversions are limited [4]. Additionally, experts in the field of infant nutrition recommend that formulas for infants should provide ARA [45]. Therefore, the synthesized SLs would be a substitute approach to use ARA directly in IF.
At sn-1,3 positions of synthesized SLs, ARA, caprylic, capric, and lignoceric acids were the most abundant FAs calculated for 30.28, 22.53, 13.8, and 9.43%, respectively. While at the sn-1,3 positions of both commercial IFs, CIFL (1) and CIFL (2), the oleic, linoleic, and palmitic acids were the most abundant FAs accounted for (42.53, 22.29, and 13.91%) and (55.22, 21.8, and 8.12%), respectively. SLs contained higher amounts of MCFAs (caprylic and capric) at the sn-1,3 positions and LCUFAs (particularly ARA) at the sn-2 position, i.e., making them new and excellent fat substrates for the addition in IFs as a compared with commercial IFs. Additionally, the replacement of LCFAs by MCFAs at the sn-1,3 positions might yield SLs with functional characteristics for infants, including rapid energy provision, protection from harmful microorganisms, and improve fat absorption and melting point [46, 47]. Caprylic acid and capric acid were mostly found at the sn-1,3 positions in IFs and in mature human milk, except capric acid in IFs prepared using cow milk and goat milk was similarly distributed between sn-2 and sn-1,3 positions [34]. Numerous studies have used ARA-SCO from Mortierella alpine and MCFAs as substrates to produce SLs enriched with MCFAs at sn-1,3 positions and ARA at the sn-2 position for the potential functional application in IFs [8, 30, 48, 49]. Moreover, FAO/WHO recommended that the formulation of IF should be enhanced with ARA [50]. Hence, the obtained SLs (SLs enriched with MLCTs), containing 42.82% ARA at the sn-2 position and 36.33% of MCFAs at the sn-1,3 positions, might have potential functional applications in the dairy industry, particularly in IFs.
Profiling of TAGs molecular species composition
The identification of TAGs is one of the characteristics that is used to know the structural and functional features of the final oil products [51]. The parameters of the chromatographic technique were optimized to get the best elution conditions for better separation of TAGs molecular species. The ammoniated TAG ion (M + NH4)+ was identified as the precursor m/z in electro spray ionization positive mode. Figure 1 shows the UPLC-Q-TOF-MS chromatograms of SL, CIFL (1), and CIFL (2). Table 3 displays the relative percent of TAG ions relative to the total percent of (TAG + NH4)+ in the three lipid samples. In the SLs enriched with MLCTs, a total of 45 different TAG species were detected. The most abundant TAG species were those of m/z 808.62, m/z 872.74, m/z 676.49, m/z 900.75, m/z 788.72, m/z 968.77, m/z 836.63, m/z 648.48, m/z 740.71, m/z 628.48, and m/z 704.6 with the relative contents 6.44%, 6.39%, 5.68%, 4.36%, 4.01%, 3.44%, 3.36%, 3.33%, 3.27%, 3.16%, and 3.05%, respectively. These findings showed that the types of MLCTs obtained contain a structure (MLM, MML, LMM, LLM, LML, and MLL) with caprylic and capric acids as the MCFAs and ARA as LCUFAs. It might allow appropriate conditions for digestion and absorption. This unique phenomenon makes it more beneficial for human health, particularly for infants [18]. A total of 38 TAG species were identified in CIFL (1). As can be observed, (18:2–18:2–18:2), (18:1–18:2–18:1), (18:1–18:1–16:0), (18:1–18:2–16:0), (18:1–18:3–16:0), (18:0–18:1–18:1), and (12:0–10:0–14:0) were the major TAG molecular species making up 11.88%, 11.70%, 9.43%, 8.62%, 8.23%, 5.02%, and 4.56%, respectively. While twenty-five different TAG species were found in CIFL (2), and the majority included (18:1–18:2–18:1), (12:0–14:0–10:0), (12:0–12:0–10:0), (18:1–16:0–18:1), (18:0–18:0–18:2), (18:2–18:2–16:0), (12:0–12:0–14:0), (18:1–16:0–18:2), and (12:0–12:0–8:0/12:0–10:0–10:0) accounted for 11.43%, 11.24%, 9.45%, 8.89%, 8.85%, 8.27%, 7.38%, 6.65%, and 6.24%, respectively. Most IFs are usually enriched with oleic, linoleic, and palmitic acids [3, 52, 53]. But, because of the lower level of lipase in newborns, the starter IF was formed with medium-chain triacylglycerols to provide energy directly [54]. Therefore, it was a great relevance to obtain SLs containing EFAs and MCFAs with easy absorption features for infants. Later, Tu et al. [54] reported that TAG species with MCFAs are present in human milk which make attention to the researchers to incorporate MCFAs into the IF due to its health’s beneficial effect [18]. There were variances in TAG species (particularly ECN ≤ 40) between the three lipid formulas due to the presence of MCFAs. Similar results were discovered in commercial IFs specially prepared using goat and cow milks [53, 54]. As we know, MCFAs are absorbed more easily than LCFAs by newborns, which can be easily oxidized and produce energy for newborns [18]. So, in general, the medium-chain triacylglycerols are added into formulas for infants with malabsorption and premature infants. Furthermore, some studies revealed that SLs with MCFAs at the sn-1,3 positions and EFAs / LCUFAs at the sn-2 position could increase absorption of EFAs and LCUFAs in cystic fibrosis syndromes and malabsorption [55, 56].
Melting and crystallization profiles
The melting and crystallization profiles of SLs enriched with MLCTs compared to the fat extracted from CIFL (1) and CIFL (2) are shown, respectively, in Fig. 2a, b. The melting and crystallization points are important to know fats/oils physical conditions inside the human body. The melting and crystallization thermograms of fats/oils are linked to both of FAs and TAGs types. The thermograms of SLs enriched with MLCTs, CIFL (1), and CIFL (2) revealed multiple peaks, representing the complexity of the TAGs distribution. The SLs enriched with MLCTs presented three melting peaks at − 21.24 °C, 11.98 °C, and 29.04 °C and three crystallization peaks at − 40.37 °C, − 0.72 °C, and 24.07 °C. As can be seen, the SLs enriched with MLCTs revealed low melting and crystallization temperatures. This reduction in melting and crystallization temperatures of SLs enriched with MLCTs may have happened due to the high content of medium chains and unsaturated FAs [47]. The vegetable oil blend used in CIFL (1) was formulated from (Corn, rapeseed, coconut, sunflower, soybean, and peanut oils), while in CIFL (2), it was formulated from (sunflower, soybean, and coconut oils) as maintained in the ingredients label. The melting and crystallization temperatures of fat extracted from CIFL (1) were (− 43.04 °C, − 19.16 °C, 12.61 °C) (− 51.43 °C, − 20.84 °C, − 6.25 °C) and for CIFL (2) were (− 37.02 °C, − 15.46 °C, − 1.57 °C, and 20.86 °C) (− 27.01 °C, − 8.50 °C, − 1.67 °C), respectively. The different melting and crystallization temperatures between CIFL (1) and CIFL (2) are related to the source of the plant oils blend. Similar behavior was found by Nagachinta, Akoh [3]. Overall, the melting temperatures of all the samples were below body temperature (37 °C). This confirms that the metabolism of the three samples would be completely melted at the body temperature. Moreover, these findings suggested the use of these SLs enriched with MLCTs as a complementary fat in IFs with a mixture including unsaturated oil (ARA-rich single-cell oil) would be a better substitute for a plant oil mixture.
Characterization of powdered IFs
Generally, powdered IF is produced by one of two kinds of the method, either dry-mixing method or wet-mixing/spray-drying method [36, 37]. Also, some producers use a combination of these methods to spray-drying the base powder (fat and protein constituent) first, then dry-blending process with carbohydrate, mineral, and vitamin constituents. To decide which method is appropriate for SLs enriched with MLCTs application in powdered IF, the powdered IFs were set with SLs enriched with MLCTs as the fat source by these two common processes and then, assessed the peroxide value, water activity, moisture content, and Hunter color values (L*, a*, b*, C*, h*, and ΔE*) of the products. Peroxide value is an index to measure the hydroperoxide amount (primary oxidation products) of oil and fat [57]. The dry-mixing method resulted in products with significantly lower peroxide value, water activity, and moisture content values compared to the wet-mixing/spray-drying method and the commercial IFs are shown in Table 4. The higher peroxide values of commercial IFs may be attributed due to the higher content of LCUFAs in the used oil as mentioned in Table 2. Meanwhile, it was found that the moisture content and water activity of all the powdered IF products were below 3% and 0.30, respectively, which were normally considered ensuring product stability [58].
After the dry-blending process, the lightness (L*) value of the powder increased, while the redness (a*) and yellowness (b*) values decreased in comparison to powder obtained from commercial and wet-mixing/spray-drying method. These findings suggested that the increased lightness of the IF product would be responsible for decreasing the PV value. In addition, the microencapsulation process of oils has the ability to improve oxidative stability with a good appearance [59]. Moreover, the Chroma (C*) values of dry-blending process products were also less, meaning that the color looked light. On the contrary, L* value decreased, while both a* and b* values increased after the wet-mixing/spray-drying process that turns the IF products into dark. The darkness of the IF products may have attributed to increase the peroxide value. A similar finding was reported by Nagachinta, Akoh [3], they stated that the lightness value was negatively associated with PV and TBARS values. Furthermore, the Chroma (C*) color values of wet-mixing/spray-drying products also were more, meaning that the color looked darker. Overall, the hue (h*) color values of all the powdered products fall among yellow and green. The total color difference (ΔE*) was well visible for dry-blending process products, while greatly visible for wet-mixing/spray-drying process products and commercial IFs [60]. These findings are in agreement with Nagachinta, Akoh [3], who reported that the IFs prepared with microencapsulated SL and using dry-mixing method had better color quality and oxidative stability.
Energy contribution of potential IF
In this work, IF preparation was targeted at a formulation that donates between 60 kcal (250 kJ) and 70 kcal (295 kJ) of energy per 100 mL of re-suspended IF resulting from 5.4 to 8.1% carbohydrates, 3.3 to 6.0% fat, and 1.2 to 3.0% protein. The IF prepared via the wet-mixing/spray-drying method provided the energy contribution by 67.01 kcal/100 mL as shown in Table 5. According to the CODEX STAN, IFs must provide between 60 and 70 kcal of energy per 100 mL [61]. For IF prepared via dry-blending method, microencapsulated SLs enriched with MLCTs contained 25% fat (SLs enriched with MLCTs), 37.5% protein (WPI), and 37.5% carbohydrate (IN). Microencapsulation of SLs enriched with MLCTs improved the final product stability (Table 4); furthermore, the energy donated from carbohydrate and protein ingredients used as encapsulated agents that increased the energy contribution of the final product by 86.4 kcal/100 mL (Table 5).
Conclusion
In this study, SLs enriched with MLCTs contained ARA (42.82 ± 0.89%) at the sn-2 position and enriched with MCFAs (36.33 ± 1.05%) at sn-1,3 positions, could be used in preparing a novel commercial formulas to fulfill the nutritional requirements of the infant growth and development. The results indicated that there were differences in the percentages of LCUFAs, LCFAs, MCFAs, and SCFAs between the three IFs oil reported samples. A total of 45 TAG species were detected in a novel SL followed by 38 in CIFL (1), and 25 in CIFL (2). The all IFs oil samples melted below the body temperature. The dry-mixing method was a better method for IF powder production, which provides greater oxidative stability and good color with low moisture content. The physiochemical characteristics of SLs enriched with MLCTs recommended its use as an oil mixture into IF. In the new formulation, the microencapsulation with 25% oil is being studied to develop for microencapsulated SLs enriched with MLCTs on energy contribution with highly functional and nutritional benefits. As we know, the various organizations, such as the European Union, USFDA and WHO, provide the standards to which the infant formulas must adhere. However, in this study, the novel microencapsulated (SL) formula exceeding the recommended standard in terms of energy and macronutrients. Therefore, we believe that the level of nutrients in a newly made formula should be reviewed to meet the references and avoid the possible adverse effect. Nevertheless, the investigation is going on to meet the standard before fair trade practices and to protect the consumers’ health.
Abbreviations
- IF:
-
Infant formula
- SLs:
-
Structured lipids
- EFAs:
-
Essential fatty acids
- ARA:
-
Arachidonic acid
- LCUFAs:
-
Long-chain unsaturated fatty acids
- MCFAs:
-
Medium-chain fatty acids
- MAG:
-
Monoacylglycerol
- FA:
-
Fatty acid
- LCFAs:
-
Long-chain fatty acids
- MLCTs:
-
Medium- and long-chain triacylglycerols
- TAGs:
-
Triacylglycerols
- DSC:
-
Differential scanning calorimeter
- SCFAs:
-
Short-chain fatty acids
- FAMEs:
-
Fatty acids methyl ester
- UPLC-Q-TOF-MS:
-
Ultra-performance liquid chromatography with quadrupole-time-of-flight mass spectrometry
- ECN:
-
Equivalent carbon number
- CN:
-
Total carbon number without glycerol
- DB:
-
Number of double bonds in the fatty acid
- CIFL (1):
-
Fat extracted from a commercial infant formula available in China
- CIFL (2):
-
Fat extracted from a commercial infant formula available in the USA
- IN:
-
Inulin
- WPI:
-
Whey protein isolate
- FDA:
-
Food and Drug Administration
- WHO:
-
World Health Organization
- MML:
-
Medium-, medium- and long-chain-type MLCTs
- LMM:
-
Long-, medium- and medium-chain type MLCTs
- LML:
-
Long-, medium- and long-chain-type MLCTs
- MLL:
-
Medium-, long- and long-chain-type MLCTs
- LLM:
-
Long-, long- and medium-chain-type MLCTs
- MLM:
-
Medium-, long- and medium-chain-type MLCTs
References
Abrahamse E, Minekus M, van Aken GA, van de Heijning B, Knol J, Bartke N, Oozeer R, van der Beek EM, Ludwig T (2012) Development of the digestive system—experimental challenges and approaches of infant lipid digestion. Food Dig 3(1):63–77. https://doi.org/10.1007/s13228-012-0025-x
Jeurink PV, Van Bergenhenegouwen J, Jiménez E, Knippels L, Fernández L, Garssen J, Knol J, Rodriguez J, Martin R (2013) Human milk: a source of more life than we imagine. Benef Microb 4(1):17–30
Nagachinta S, Akoh CC (2013) Synthesis of structured lipid enriched with omega fatty acids and sn-2 palmitic acid by enzymatic esterification and its incorporation in powdered infant formula. J Agri Food Chem 61(18):4455–4463
Burdge GC, Calder PC (2005) Conversion of $\alpha $-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev 45(5):581–597
Nagachinta S, Akoh C (2012) Enrichment of palm olein with long chain polyunsaturated fatty acids by enzymatic acidolysis. LWT-Food Sci Technol 46(1):29–35
Teichert SA, Akoh CC (2011) Modifications of stearidonic acid soybean oil by enzymatic acidolysis for the production of human milk fat analogues. J Agri Food Chem 59(24):13300–13310
Wang Y, Xia L, Xu X, Xie L, Duan Z (2012) Lipase-catalyzed acidolysis of canola oil with caprylic acid to produce medium-, long-and medium-chain-type structured lipids. Food Bioprod Process 90(4):707–712
Abed SM, Wei W, Ali AH, Korma SA, Mousa AH, Hassan HM, Jin Q, Wang X (2018) Synthesis of structured lipids enriched with medium-chain fatty acids via solvent-free acidolysis of microbial oil catalyzed by Rhizomucor miehei lipase. Lwt 93:306–315
Lien EL (1994) The role of fatty acid composition and positional distribution in fat absorption in infants. J Pediatr 125(5):S62–S68
Ryan AS, Astwood JD, Gautier S, Kuratko CN, Nelson EB, Salem N Jr (2010) Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies. Prost Leukotr Essential Fat Acids 82(46):305–314
Prosser C, Svetashev V, Vyssotski M, Lowry D (2010) Composition and distribution of fatty acids in triglycerides from goat infant formulas with milk fat. J Dairy Sci 93(7):2857–2862
St-Onge M-P, Mayrsohn B, O'Keeffe M, Kissileff HR, Choudhury AR, Laferrère B (2014) Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men. Eur J Clin Nutr 68(10):1134–1140
St-Onge MP, Ross R, Parsons WD, Jones PJ (2003) Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes Res 11(3):395–402
Hamam F, Shahidi F (2004) Enzymatic acidolysis of an arachidonic acid single-cell oil with capric acid. J Am Oil Chem Soc 81(9):887–892
Kasai M, Nosaka N, Maki H, Negishi S, Aoyama T, Nakamura M, Suzuki Y, Tsuji H, Uto H, Okazaki M (2003) Effect of dietary medium-and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pacific J Clin Nutr 12(2):151–160
Lee Y-Y, Tang T-K, Tan C-P, Alitheen NBM, Phuah E-T, Ab Karim NA, Lai O-M (2015) Entrapment of palm-based medium-and long-chain triacylglycerol via maillard reaction products. Food Biopro Technol 8(7):1571–1582
Matsuo T, Takeuchi H (2004) Effects of structured medium-and long-chain triacylglycerols in diets with various levels of fat on body fat accumulation in rats. Br J Nutr 91(2):219–225
Lee YY, Tang TK, Lai OM (2012) Health benefits, enzymatic production, and application of medium-and long-chain triacylglycerol (MLCT) in food industries: a review. J Food Sci 77(8):R137–R144
Innis SM (2007) Fatty acids and early human development. Early Human Dev 83(12):761–766
Van Den Burg AC, Groenendaal JW (2002) Late addition of PUFA in infant formula preparation process. Google Patents 3:8
Bakry AM, Fang Z, Khan MA, Chen Y, Chen YQ, Liang L (2017) Tuna oil and Mentha piperita oil emulsions and microcapsules stabilised by whey protein isolate and inulin: characterisation and stability. Int J Food Sci Technol 52(2):494–503
Botrel DA, Borges SV, Fernandes RVDB, Lourenço Do Carmo E (2014) Optimization of fish oil spray drying using a protein: inulin system. Dry Technol 32(3):279–290
Castro A, Céspedes G, Carballo S, Bergenståhl B, Tornberg E (2013) Dietary fiber, fructooligosaccharides, and physicochemical properties of homogenized aqueous suspensions of yacon (Smallanthus sonchifolius). Food Res Int 50(1):392–400
Turchiuli C, Munguia MJ, Sanchez MH, Ferre HC, Dumoulin E (2014) Use of different supports for oil encapsulation in powder by spray drying. Powder Technol 255:103–108
de Barros Fernandes RV, Silva EK, Borges SV, de Oliveira CR, Yoshida MI, da Silva YF, do Carmo EL, Azevedo VM, Botrel DA (2017) Proposing novel encapsulating matrices for spray-dried ginger essential oil from the whey protein isolate-inulin/maltodextrin blends. Food Bioprocess Technol 10(1):115–130
Shoaib M, Shehzad A, Omar M, Rakha A, Raza H, Sharif HR, Shakeel A, Ansari A, Niazi S (2016) Inulin: properties, health benefits and food applications. Carbohyd Polym 147:444–454
Knol J, Scholtens P, Kafka C, Steenbakkers J, Gro S, Helm K, Klarczyk M, Schöpfer H, Böckler H-M, Wells J (2005) Colon microflora in infants fed formula with galacto-and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40(1):36–42
Augustin MA, Abeywardena M, Patten G, Head R, Lockett T, De Luca A, Sanguansri L (2011) Effects of microencapsulation on the gastrointestinal transit and tissue distribution of a bioactive mixture of fish oil, tributyrin and resveratrol. J Funct Foods 3(1):25–37
Patten GS, Augustin MA, Sanguansri L, Head RJ, Abeywardena MY (2009) Site specific delivery of microencapsulated fish oil to the gastrointestinal tract of the rat. Dig Dis Sci 54(3):511–521
Korma SA, Zou X, Ali AH, Abed SM, Jin Q, Wang X (2018) Preparation of structured lipids enriched with medium-and long-chain triacylglycerols by enzymatic interesterification for infant formula. Food Bioprod Process 107:121–130
Korma SA, Wei W, Ali AH, Abed SM, Zheng L, Jin Q, Wang X (2019) Spray-dried novel structured lipids enriched with medium-and long-chain triacylglycerols encapsulated with different wall materials: characterization and stability. Food Res Int 116:538–547
Floch J (1957) A simple method for the isolation and purification of total lipids from animal tissues. J biol Chem 226:497–509
Pande G, Sabir JS, Baeshen NA, Akoh CC (2013) Synthesis of infant formula fat analogs enriched with DHA from extra virgin olive oil and tripalmitin. J Am Oil Chem Soc 90(9):1311–1318
Sun C, Wei W, Su H, Zou X, Wang X (2018) Evaluation of sn-2 fatty acid composition in commercial infant formulas on the Chinese market: a comparative study based on fat source and stage. Food Chem 242:29–36
Ali AH, Abd El-Wahed EM, Abed SM, Korma SA, Wei W, Wang X (2019) Analysis of triacylglycerols molecular species composition, total fatty acids, and sn-2 fatty acids positional distribution in different types of milk powders. J Food Measure Character 13(4):2613–2625
Masum A, Chandrapala J, Huppertz T, Adhikari B, Zisu B (2020) Influence of drying temperatures and storage parameters on the physicochemical properties of spray-dried infant milk formula powders. Internat Dairy J 2:104696
O'Callaghan DM, O'Mahony JA, Ramanujam KS, Burgher AM (2011) Dehydrated Dairy Products | Infant Formula. In: Encyclopedia of dairy sences, pp 135–145
Sharif HR, Goff HD, Majeed H, Shamoon M, Liu F, Nsor-Atindana J, Haider J, Liang R, Zhong F (2017) Physicochemical properties of β-carotene and eugenol co-encapsulated flax seed oil powders using OSA starches as wall material. Food Hydrocoll 73:274–283
Ahmed M, Akter MS, Lee J-C, Eun J-B (2010) Encapsulation by spray drying of bioactive components, physicochemical and morphological properties from purple sweet potato. LWT-Food Sci Technol 43(9):1307–1312
Abed SM, Elbandy M, Abdel-Samie MA, Ali AH, Korma SA, Noman A, Wei W, Jin Q (2020) Screening of lipases for production of novel structured lipids from single cell oils. Process Biochem 91:181–188
Ji X-J, Ren L-J, Nie Z-K, Huang H, Ouyang P-K (2014) Fungal arachidonic acid-rich oil: research, development and industrialization. Crit Rev Biotechnol 34(3):197–214
Osborn H, Akoh C (2002) Structured lipids-novel fats with medical, nutraceutical, and food applications. Compr Rev Food Sci Food Safety 1(3):110–120
Tang W, Wang X, Huang J, Jin Q, Wang X (2015) A novel method for the synthesis of symmetrical triacylglycerols by enzymatic transesterification. Biores Technol 196:559–565
Christensen MM, Høy C-E (1997) Early dietary intervention with structured triacylglycerols containing docosahexaenoic acid. Effect on brain, liver, and adipose tissue lipids. Lipids 32(2):185–191
Koletzko B, Bergmann K, Brenna JT, Calder PC, Campoy C, Clandinin MT, Colombo J, Daly M, Decsi T, Demmelmair H (2020) Should formula for infants provide arachidonic acid along with DHA? A position paper of the European Academy of Paediatrics and the Child Health Foundation. Am J Clin Nutr 111(1):10–16
Mounika C, Reddy SY (2012) Specialty fats enriched with behenic and medium chain fatty acids from palm stearin by lipase acidolysis. J Am Oil Chem Soc 89(9):1691–1697
Álvarez CA, Akoh CC (2016) Preparation of infant formula fat analog containing capric acid and enriched with DHA and ARA at the sn-2 position. J Am Oil Chem Soc 93(4):531–542
Abed SM, Zou X, Ali AH, Jin Q, Wang X (2017) Synthesis of 1, 3-dioleoyl-2-arachidonoylglycerol-rich structured lipids by lipase-catalyzed acidolysis of microbial oil from Mortierella alpina. Biores Technol 243:448–456
Lu J, Jin Q, Wang X, Wang X (2017) Preparation of medium and long chain triacylglycerols by lipase-catalyzed interesterification in a solvent-free system. Process Biochem 54:89–95
Fao R (2010) Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition Eng-Nov Geneva (2010) Fats and fatty acids in human nutrition. report of an expert consultation, 10–14 November 2008 Geneva
Xie W, Zang X (2018) Lipase immobilized on ionic liquid-functionalized magnetic silica composites as a magnetic biocatalyst for production of trans-free plastic fats. Food Chem 257:15–22
Zou X-Q, Huang J-H, Jin Q-Z, Guo Z, Liu Y-F, Cheong L-Z, Xu X-B, Wang X-G (2013) Model for human milk fat substitute evaluation based on triacylglycerol composition profile. J Agri Food Chem 61(1):167–175
Sun C, Wei W, Zou X, Huang J, Jin Q, Wang X (2018) Evaluation of triacylglycerol composition in commercial infant formulas on the Chinese market: a comparative study based on fat source and stage. Food Chem 252:154–162
Tu A, Ma Q, Bai H, Du Z (2017) A comparative study of triacylglycerol composition in Chinese human milk within different lactation stages and imported infant formula by SFC coupled with Q-TOF-MS. Food Chem 221:555–567
Christensen MS, Høy C, Becker CC, Redgrave TG (1995) Intestinal absorption and lymphatic transport of eicosapentaenoic (EPA), docosahexaenoic (DHA), and decanoic acids: dependence on intramolecular triacylglycerol structure. Am J Clin Nutr 61(1):56–61
Christensen MS, Müllertz A, Høy CE (1995) Absorption of triglycerides with defined or random structure by rats with biliary and pancreatic diversion. Lipids 30(6):521–526
Gotoh N, Wada S (2006) The importance of peroxide value in assessing food quality and food safety. JAOCS J Am Oil Chem Soc 83(5):473
Drusch S, Schwarz K (2006) Microencapsulation properties of two different types of n-octenylsuccinate-derivatised starch. Eur Food Res Technol 222(1–2):155–164
Bakry AM, Fang Z, Ni Y, Cheng H, Chen YQ, Liang L (2016) Stability of tuna oil and tuna oil/peppermint oil blend microencapsulated using whey protein isolate in combination with carboxymethyl cellulose or pullulan. Food Hydrocoll 60:559–571
Sanchez-Reinoso Z, Gutiérrez L-F (2017) Effects of the emulsion composition on the physical properties and oxidative stability of sacha inchi (Plukenetia volubilis L.) oil microcapsules produced by spray drying. Food Bioprocess Technol 10(7):1354–1366
Codex S (2007) STAN 72-1981. Codex Alimentarius WHO/FAO standard for infant formula and formulas for special medical purposes Intended for Infants Available online: http://www codexalimentarius org/standards (Accessed on 20 Janu 2014)
Singh P, Kesharwani RK, Keservani RK (2017) 6 - Protein, Carbohydrates, and Fats: Energy Metabolism. In: Bagchi D (ed) Sustained energy for enhanced human functions and activity. Academic Press, pp 103–115. https://doi.org/10.1016/B978-0-12-805413-0.00006-5
Acknowledgements
This work was financially supported by the National Natural Science Foundation of China Grant (31701558) and Fundamental Research Funds for the Central Universities (JUSRP11734).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This article does not contain any studies with human or animals and complies with ethical requirements.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Korma, S.A., Li, L., Abdrabo, K.A.E. et al. A comparative study of lipid composition and powder quality among powdered infant formula with novel functional structured lipids and commercial infant formulas. Eur Food Res Technol 246, 2569–2586 (2020). https://doi.org/10.1007/s00217-020-03597-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00217-020-03597-7